Nucleus Biologics Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Nucleus Biologics's estimated annual revenue is currently $12.7M per year.(i)
  • Nucleus Biologics's estimated revenue per employee is $155,000

Employee Data

  • Nucleus Biologics has 82 Employees.(i)
  • Nucleus Biologics grew their employee count by -4% last year.

Nucleus Biologics's People

NameTitleEmail/Phone
1
Founder, President and CEOReveal Email/Phone
2
CFOReveal Email/Phone
3
SVP CommercialReveal Email/Phone
4
VP SalesReveal Email/Phone
5
VP MarketingReveal Email/Phone
6
VP ManufacturingReveal Email/Phone
7
VP Sales Enablement and Customer ExperienceReveal Email/Phone
8
Director Quality and RegulatoryReveal Email/Phone
9
Director Supply Chain, Logistics and FacilitiesReveal Email/Phone
10
R&D DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Nucleus Biologics?

Nucleus Biologics is a San Diego based biotechnology company and a global provider of media and supplements for the cell and gene therapy space. Their mission is to speed the time from scientific discovery to cure by driving reproducibility through Precision Cell Culture products and tools. Nucleus Biologics delivers innovative, transparent and cGMP products and services with the goal of disrupting the market and eliminating antiquated practices and products. Ultimately, Nucleus Biologics strives to create a new paradigm that serves both scientists and clinicians, while reducing the environmental footprint of cell culture.

keywords:N/A

N/A

Total Funding

82

Number of Employees

$12.7M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.8M8234%N/A
#2
$11.9M82N/AN/A
#3
$11.9M826%$59.8M
#4
$11.9M8237%N/A
#5
$11.9M825%N/A